Clinical Trials Directory

Trials / Completed

CompletedNCT03631290

Deprescribing for Older Dialysis Patients

Status
Completed
Phase
Study type
Observational
Enrollment
48 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

Aim 1 of the study is to identify the elements of a deprescribing intervention that address contextual factors specific to dialysis. Aim 2 of the study, described in this record, is to determine the feasibility of a deprescribing intervention tailored for older dialysis patients. Older adults receiving dialysis are often prescribed multiple medications. Some of these medications are used to treat symptoms, but they also can increase the chance of significant health problems. The purpose of this study is to identify if it is feasible to reduce the use of medications that have been identified as causing an increased risk for health problems.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDeprescribing InterventionThe deprescribing program was implemented as a clinical quality improvement project for patients receiving dialysis. Patients taking specific potentially inappropriate medications (PIMs) were identified in the medical record. The PIMs of interest included gabapentinoids, clonidine, alpha blockers, muscle relaxants, and Z-drugs. If their nephrologist agreed to attempt deprescribing the PIM, either the nephrologist (Provider Only Communication) or a study team member (pharmacist or nurse, Provider/Patient Communication) would engage the patient in discussion about deprescribing. This discussion included patient education materials about the risk of the medication. If the patient agreed, they were provided taper instructions (if indicated) and were followed up at 1 month and 3 months. The patient was also invited to enroll in a study to be interviewed about the deprescribing decision and experience, and undergo brief assessment of geriatric problems at baseline and at 3 months.

Timeline

Start date
2022-03-09
Primary completion
2023-12-13
Completion
2023-12-13
First posted
2018-08-15
Last updated
2025-02-03
Results posted
2025-02-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03631290. Inclusion in this directory is not an endorsement.